Ampliphi Biosciences Corp (NYSEAMERICAN:APHB – Get Free Report)’s stock price crossed below its fifty day moving average during trading on Friday . The stock has a fifty day moving average of $5.19 and traded as low as $4.73. Ampliphi Biosciences shares last traded at $5.43, with a volume of 270,464 shares traded.
Ampliphi Biosciences Stock Down 1.1%
The business’s 50 day moving average is $5.19 and its two-hundred day moving average is $7.95.
About Ampliphi Biosciences
Ampliphi Biosciences, Inc is a clinical‐stage biopharmaceutical company headquartered in Cambridge, Massachusetts, focused on the discovery and development of novel therapies to prevent and treat life‐threatening drug‐resistant infections. The company’s core mission is to address the growing global threat of antibiotic resistance by advancing first‐in‐class and best‐in‐class antibacterial agents through late‐stage clinical trials.
The company’s lead product candidate, exeporfinium chloride (XF-73), is a pioneering topical antibacterial designed for pre‐operative nasal decolonization of Staphylococcus aureus in patients undergoing high‐risk surgical procedures.
Recommended Stories
- Five stocks we like better than Ampliphi Biosciences
- OneMain’s Yield Comes With a Catch
- 3 AI Infrastructure Stocks to Watch Beyond NVIDIA
- From SaaS-pocalypse to Perfect Storm: Workday’s AI Growth Story Strengthens
- These 3 GARP Stocks Show Why Growth and Value Do Not Have to Clash
Receive News & Ratings for Ampliphi Biosciences Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Ampliphi Biosciences and related companies with MarketBeat.com's FREE daily email newsletter.
